FindTrial
Sign In

Changes of proteomics and protein-interaction in peripheral blood monocytes before and after treatment in first-episode schizophrenia

Changes of proteomics and protein-interaction in peripheral blood monocytes before and after treatment in first-episode schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028028
Enrollment
Unknown
Registered
2019-12-08
Start date
2019-12-16
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

schizophrenia:none
healthy control:none

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of DSM-? : schizophrenia, after the SCID scan; 2. Demographic information standard: Age: 12-60 years; Ethnicity: Han; Right hand; 3. Have not taken any antidepressants, antipsychotics or sedatives before.

Exclusion criteria

Exclusion criteria: 1. People with severe physical and neurological diseases; 2. Meet any other diagnosis of mental disorder that in DSM-IV; 3. Those who cannot complete the inspection effectively, such as color blindness.

Design outcomes

Primary

MeasureTime frame
proteins of peripheral blood monocyte;—

Secondary

MeasureTime frame
function of cognition;clinical symptoms;—

Countries

China

Contacts

Public ContactTao Li

West China Hospital, Sichuan University

xuntao26@hotmail.com+86 18980601817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026